Epithelial–immune crosstalk in lung transplant ischemia–reperfusion injury

Understanding epithelial-immune crosstalk reveals new avenues for mitigating PGD by targeting epithelial pathways and innate immune effector cells. These insights can inform future therapies to improve lung transplant outcomes and mitigate additional allograft injuries.